Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Christopher U. Missling,PhD$282.5M
Market Cap • 26/04/20242004
(há 20 anos)
2006
(18 years ago)
NASDAQ
Listagem
New York
Sede • New York38
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
AVXLSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.